Page last updated: 2024-10-27

flumazenil and Bare Lymphocyte Syndrome

flumazenil has been researched along with Bare Lymphocyte Syndrome in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baffelli, R1
Notarangelo, LD1
Imberti, L1
Hershfield, MS1
Serana, F1
Santisteban, I1
Bolda, F1
Porta, F1
Lanfranchi, A1

Other Studies

1 other study available for flumazenil and Bare Lymphocyte Syndrome

ArticleYear
Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.
    Journal of clinical immunology, 2015, Volume: 35, Issue:7

    Topics: Adenosine Deaminase; Agammaglobulinemia; Child, Preschool; Consanguinity; DNA Mutational Analysis; E

2015